On January 7, 2025 Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, reported that John S. Yu, M.D., Chief Executive Officer, and Neil Bhowmick, Chief Scientific Officer, will present a corporate overview at the Lytham Partners Investor Healthcare Summit (Press release, Kairos Pharma, JAN 7, 2025, View Source [SID1234649488]). The conference is being held virtually on January 13, 2025.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event:

Lytham Partners Investor Healthcare Summit

Presentation Date:

Monday, January 13, 2025

Time:

2:00 PM ET

Webcast Link:

View Sourcekapa" target="_blank" title="View Sourcekapa" rel="nofollow">View Source

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners or register for the event at View Source

The webcast will also be available for replay following the event.